Prana Biotechnology Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$17.52 M |
Shares Outstanding |
533.89 M |
Public Float |
- |
Prana Biotechnology Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.02 |
Market Cap |
AUD23.63 M |
Shares Outstanding |
536.98 M |
Public Float |
518.37 M |
Prana Biotechnology Ltd. ADR | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR0.71 |
Market Cap |
EUR15.78 M |
Shares Outstanding |
8.95 M |
Public Float |
- |
Prana Biotechnology Ltd. ADR | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.72 |
Market Cap |
$16.76 M |
Shares Outstanding |
8.95 M |
Public Float |
- |
Address |
460 Bourke Street Melbourne Victoria (VIC) 3000 Australia |
Employees | - |
Website | http://www.pranabio.com |
Updated | 07/08/2019 |
Prana Biotechnology Ltd. engages in the development of therapy treatment for neurodegenerative disease. It includes research and development of treatments for Alzheimer's and Huntington's disease. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia. |